Global Hepatocellular Carcinoma (HCC) Epidemiology Forecast to 2027, With Coverage of 8 Major Markets Including United States, EU5 Countries, China & Japan - ResearchAndMarkets.com | Financial Buzz

Global Hepatocellular Carcinoma (HCC) Epidemiology Forecast to 2027, With Coverage of 8 Major Markets Including United States, EU5 Countries, China & Japan – ResearchAndMarkets.com

The “Hepatocellular
Carcinoma (HCC) – Epidemiology Forecast to 2027” report has
been added to ResearchAndMarkets.com’s offering.

The disease epidemiology covered in the report provides historical as
well as forecasted epidemiology (total incident cases, diagnosed
incidence of advanced HCC, total patients on therapies (patients by line
of therapies) scenario of Hepatocellular Carcinoma in the G8 covering
United States, EU5 countries (Germany, Spain, Italy, France and United
Kingdom), China and Japan from 2016-2027.

The report also provides the epidemiology trends observed in the G8
countries during the study period, along with the assumptions
undertaken. The calculated data are presented with relevant tables and
graphs to give a clear view of the epidemiology at first sight.

According to this research, the total number of incident cases of
Hepatocellular Carcinoma was found to be 458,170, in the year 2016 in G8
countries.

Report Scope:

Key assessments:

Key Topics Covered:

1. Key Insights

2. Disease Background and Overview: Hepatocellular Carcinoma

3. Epidemiology and Patient Population

4. Key Findings

5. Population and Forecast Parameters

6. Country Wise-Epidemiology of HCC

7. Appendix

8. Report Methodology

9. Capabilities

10. Disclaimer

11. About the Publisher

For more information about this report visit https://www.researchandmarkets.com/research/72hb3s/global?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20180622005176/en/